Mark Wilterding | SVP, IR and Treasurer |
Bernard Zovighian | CEO |
Scott Ullem | CFO |
Larry Wood | Group President, TAVR and Surgical Structural Hear |
Daveen Chopra | Global Leader of TMTT |
Robbie Marcus | JPMorgan |
Matthew Taylor | Jefferies |
Vijay Kumar | Evercore ISI |
Larry Biegelsen | Wells Fargo |
Travis Steed | Bank of America |
Josh Jennings | Cowen |
Chris Pasquale | Nephron |
Matt Miksic | Barclays |
Danielle Antalffy | UBS |
Richard Newitter | Truist Securities |
Pito Chickering | Deutsche Bank |
Adam Maeder | Piper Sandler |
Greetings, and welcome to the Edwards Lifesciences Second Quarter 2023 Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note that this conference is being recorded.
I will now turn the conference over to our host, Mark Wilterding, Senior Vice President, Investor Relations and Treasurer.